| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jun 10, 2021 |
Director
Trans History: 11
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,528 | -- | 7,528 |
| Jun 10, 2021 |
Director
Trans History: 9
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,528 | -- | 7,528 |
| Jun 10, 2021 |
Director
Trans History: 14
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,528 | -- | 7,528 |
| Jun 10, 2021 |
Director
Trans History: 8
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,528 | -- | 7,528 |
| Jun 08, 2021 |
Chief Commercial Officer
Trans History: 2
|
Chief Commercial Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Jun 01, 2021 |
Chief Commercial Officer
Trans History: 2
|
Chief Commercial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 400,000 | -- | 400,000 |
| May 26, 2021 |
Chief Financial Officer
Trans History: 14
|
Chief Financial Officer | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | $0.56 | 33,000 |
| May 26, 2021 |
Chief Financial Officer
Trans History: 14
|
Chief Financial Officer | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | -- | 200,000 |
| May 12, 2021 |
Director, President and CEO
Trans History: 27
|
Director, President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 290,000 | -- | 295,191 |
| May 12, 2021 |
Director, President and CEO
Trans History: 27
|
Director, President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 290,000 | -- | 585,191 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.